Inhibition of NLRP3 inflammasome as a therapeutic intervention in crystal-induced nephropathy

Kidney International

Volumn 90, Issue 3, 2016, Pages 466-468

  Sakai, Norihiko ^a   Furuichi, Kengo ^a   Wada, Takashi ^b  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM OXALATE; CP 456773; CREATININE; CRYOPYRIN; GLYCOPROTEIN P 15095; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; UREA; INFLAMMASOME;

APOPTOSIS; BONE MARROW DERIVED MACROPHAGE; CREATININE BLOOD LEVEL; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME INHIBITION; EPITHELIUM CELL; HUMAN; IN VIVO STUDY; INNATE IMMUNITY; KIDNEY DYSFUNCTION; KIDNEY FIBROSIS; KIDNEY TUBULE DISORDER; LUCIFERASE ASSAY; NONHUMAN; NOTE; PATHOGENESIS; PRIORITY JOURNAL; TUBULOINTERSTITIAL FIBROSIS; UREA NITROGEN BLOOD LEVEL; ANIMAL; IMMUNOLOGY; KIDNEY; KIDNEY DISEASE; MOUSE;

ANIMALS; HUMANS; IMMUNITY, INNATE; INFLAMMASOMES; INTERLEUKIN-1BETA; KIDNEY; KIDNEY DISEASES; MICE;

EID: 84994275552     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1016/j.kint.2016.05.003     Document Type: Note

References (9)

1. 1 Takeuchi, O., Akira, S., Pattern recognition receptors and inflammation. Cell 140 (2010), 805–820.
2. 2 Hutton HL, Ooi JD, Holdsworth SR, Kitching AR. The NLRP3 inflammasome in kidney disease and autoimmunity [e-pub ahead of print]. Nephrology (Carlton). http://dx.doi.org/10.1111/nep.12785. Accessed May 31, 2016.
3. 3 Mulay, S.R., Kulkarni, O.P., Rupanagudi, K.V., et al. Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1β secretion. J Clin Invest 123 (2013), 236–246.
4. 4 Ludwig-Portugall, I., Bartok, E., Dhana, E., et al. An NLRP3-specific inflammasome inhibitor attenuates crystal-induced kidney fibrosis in mice. Kidney Int 90 (2016), 525–539.
5. 5 Bartok, E., Bauernfeind, F., Khaminets, M.G., et al. iGLuc: a luciferase-based inflammasome and protease activity reporter. Nat Methods 10 (2013), 147–154.
6. 6 Laliberte, R.E., Perregaux, D.G., Hoth, L.R., et al. Glutathione s-transferase omega 1-1 is a target of cytokine release inhibitory drugs and may be responsible for their effect on interleukin-1beta posttranslational processing. J Biol Chem 278 (2003), 16567–16578.
7. 7 Wang, J., Wen, Y., Lv, L.L., et al. Involvement of endoplasmic reticulum stress in angiotensin II-induced NLRP3 inflammasome activation in human renal proximal tubular cells in vitro. Acta Pharmacol Sin 36 (2015), 821–830.
8. + efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38 (2013), 1142–1153.
9. 9 Zhou, R., Yazdi, A.S., Menu, P., Tschopp, J., A role for mitochondria in NLRP3 inflammasome activation. Nature 469 (2011), 221–225.